Angiogenesis is critical to both the growth and repair of tissues as well as for the progression of several pathologies. Progress in our molecular understanding of vascular growth has facilitated the development of therapies that have been successfully applied in diseases such as retinopathy and cancer. Notwithstanding these advancements, much remains to be harnessed from the basic molecular mechanisms that control vascular growth. This conference will bring together leaders of research from basic science, translational science, biotechnology and pharmaceutical areas, to discuss progress in clinical and translational research areas. The goal of the conference is to highlight new discoveries, technological advances and therapeutic possibilities. Both established and up-and-coming investigators will have ample opportunities to interact informally and share views with junior investigators and trainees in a collegial and relaxed atmosphere. By promoting cross-disciplinary interactions, the meeting will enhance vascular biology research and applications to clinical medicine.